Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Feature
Nature Biotechnology 24, 1521–1528 (1 December 2006) | doi:10.1038/nbt1206-1521
The business of developing antibacterials
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
